M. Lavie

Prolonged response times characterize cognitive performance in multiple sclerosis

G. Doniger, A. Achiron, E. Simon, 2007, European journal of neurology.

Modeling of Cognitive Impairment by Disease Duration in Multiple Sclerosis: A Cross-Sectional Study

G. Doniger, A. Achiron, J. Chapman, 2013, PloS one.

Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves

S. Rao, A. Achiron, Y. Barak, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.

A. Achiron, M. Faibel, D. Magalashvili, 2004, Archives of neurology.

Detection of Cognitive Impairment in Multiple Sclerosis Based on P300 Event-Related Potential

A. Achiron, G. Zeilig, M. Zwecker, 2018 .

T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients.

I. Cohen, A. Achiron, M. Faibel, 2004, Clinical immunology.

Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process

A. Achiron, Y. Harel, M. Lavie, 2009, Journal of the Neurological Sciences.

Screening for early cognitive impairment in multiple sclerosis patients using the clock drawing test

A. Achiron, Y. Barak, M. Lavie, 2002, Journal of Clinical Neuroscience.